From Disappointment to Predominance: Medicare Advantage's Ascendancy and Transformation of Medicare
The Milbank Quarterly · 2025-09 · 103 (3) · 652-675
DOI: 10.1111/1468-0009.70042 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Milbank Quarterly, online erschienen am 31.07.2025. Verfasst von Rick Mayes und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Richmond and UVA School of Nursing. Hauptthemen laut MEDLINE: Medicare Part C, Health Care Reform, Medicare. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Policy Points Since 2004, beneficiaries in government‐administered traditional Medicare decreased by about 3 million (8%), whereas enrollment in Medicare Advantage (MA) plans run by private insurance companies increased by approximately 30 million (500%). MA's growth has exceeded the adequate evolution and refinement of the program's regulatory apparatus. MA now annually costs at least 20% (around $84 billion) more than what Medicare would have spent if all MA enrollees were in traditional Medicare (TM). This differential in payments has advantaged MA relative to TM and transformed the Medicare program in part by corporatizing it for tens of millions of beneficiaries. Most MA revenue now flows to large, increasingly vertically integrated, multinational, for‐profit companies that are reshaping the US health care landscape for all patients, providers, and payers. Overpayments have strengthened the political position of the largest MA plan providers such that the program is at risk of interest group capture because of their powerful lobbying and political influence. Reforming MA should include the following: (a) ongoing improvements to the program's risk adjustment system and benchmark policy for rate setting, (b) replacing the quality bonus program with a value incentive program that is budget‐neutral, and (c) standardizing MA plans into a small number of basic plan categories and having private health companies make competitive bids in each of them to compete on price instead of on benefit offerings. Savings from any MA payment reforms could shore up Medicare's Hospital Trust Fund or improve TM for a “Medicare 2.0” that competes on a more level playing field with MA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Richmond and UVA School of Nursing.
- Brigham and Women's Hospital, Harvard Medical School.
ORCID-Profile: Rick Mayes, Micah Johnson
Zitieren
APA
Mayes, R., & Johnson, M. (2025). From Disappointment to Predominance: Medicare Advantage's Ascendancy and Transformation of Medicare. The Milbank Quarterly, 103(3), 652-675. https://doi.org/10.1111/1468-0009.70042
Vancouver
Mayes R, Johnson M. From Disappointment to Predominance: Medicare Advantage's Ascendancy and Transformation of Medicare. The Milbank Quarterly. 2025;103(3):652-675. doi:10.1111/1468-0009.70042
BibTeX
@article{Mayes2025,
author = {Mayes, Rick and Johnson, Micah},
title = {From Disappointment to Predominance: Medicare Advantage's Ascendancy and Transformation of Medicare},
journal = {The Milbank Quarterly},
year = {2025},
volume = {103},
number = {3},
pages = {652--675},
doi = {10.1111/1468-0009.70042}
}
EUVIMED